CIO
MAY 15, 2024
Or a functional and line-of-business executive asking, “What does genAI mean to how we create value?” The biotech company Moderna , for example, is aiming to use ChatGPT Enterprise to “automate nearly every business process” in order to “outpace its plan to roll out 15 new products within the next five years.”
CIO
NOVEMBER 30, 2022
Seemingly since the beginning of time, CIOs have been working to change their IT organizations from “order takers” into “business partners.” Yes, most IT leadership teams have stronger relationships with their business partners than, say, five years ago, but there is still a long way to go.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ArchIntel
JANUARY 26, 2021
The Greater Boston Area-based senior manager’s primary responsibilities include monitoring competitor and customer activities, direct threat assessments , and ensuring that the biotech company is in an optimal competitive position in terms of its product releases.
CIO
OCTOBER 5, 2022
“Most people consider the CIO to be a technology person, and they want to put them in a technology box, but technology should be only 20% of a CIO’s job,” says Hadari, who has been leading IT for the $15 billion biotech business since March 2021. The savvy to run IT like a business. Is it sexy and transformative?
CIO
SEPTEMBER 18, 2023
Because data and BI initiatives require a deep understanding of the business, Hsiao has taken to reskilling candidates from finance and accounting despite the fact that they had no prior technology background.
Zoominfo
APRIL 2, 2020
to discuss the future of one of the world’s largest biotech companies. Despite this, the transition to working from home is fundamentally more difficult for smaller businesses and not nearly as widespread. On February 26, 175 executives gathered at the Marriott Long Wharf hotel in Boston, Mass., of the small companies and 54.1%
Alpha Sense BI
FEBRUARY 8, 2023
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1
Expert insights. Personalized for you.
662 
Let's personalize your content